Pharma-Bio Serv (PBSV) Shares Outstanding (Weighted Average) (2010 - 2026)

Pharma-Bio Serv's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $22.9 million for Q2 2026.

• Shares Outstanding (Weighted Average) for Q2 2026 came in at $22.9 million, changed 0.19% year-over-year; the trailing twelve-month figure through Apr 2026 was $22.9 million (changed 0.19% YoY), and the FY2025 annual result was $22.9 million, changed 0.08% from the prior year.
• Shares Outstanding (Weighted Average) came in at $22.9 million for Q2 2026 at Pharma-Bio Serv, roughly flat from $22.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $23.0 million in Q4 2022 to a low of $22.9 million in Q2 2026.
• A 5-year average of $23.0 million and a median of $23.0 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) decreased 0.29% in 2022 and increased 0.08% in 2024, its largest moves.
• Over 5 years, Shares Outstanding (Weighted Average) stood at $23.0 million in 2022, then slipped by 0.14% to $23.0 million in 2023, then fell by 0.02% to $23.0 million in 2024, then fell by 0.08% to $22.9 million in 2025, then fell by 0.2% to $22.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $22.9 million (Q2 2026), $22.9 million (Q1 2026), and $22.9 million (Q4 2025), per Business Quant data.